Mathias Oelke
Founder bij NEXIMMUNE, INC.
Vermogen: 1 773 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Mathias Oelke
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mathias Oelke via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| UNITEDHEALTH GROUP INC. | Managed Health Care | Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ATHENEXPAR | Pharmaceuticals: Major | Director/Board Member | |
| PRECISION BIOSCIENCES, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Rally Health, Inc.
 Rally Health, Inc. Packaged SoftwareTechnology Services Rally Health, Inc. provides a personal health management platform that enables consumers to record fitness goals, research conditions, access health tools and even communicate directly with other members and medical professionals. Its flagship products, Zensey, is a gamified health social network and employee wellness program. Zensey consists of a place for patients to aggregate health data from providers and an anonymous forum to discuss health concerns with other members, as well as connections to various smartphone-enabled health devices. The company was founded by Gran Lovely Verstandig in 2010 and is headquartered in Washington, DC. | Packaged Software | Chief Executive Officer | |
| BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
Noble Life Sciences, Inc.
 Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| RENOVORX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Graduate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
Warburg Pincus & Company US LLC
 Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Investment Managers | Consultant / Advisor | |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Kentucky | College/University | Undergraduate Degree | |
Washington Hospital Center Corp.
 Washington Hospital Center Corp. Hospital/Nursing ManagementHealth Services Washington Hospital Center Corp. provides healthcare services. The firm has care centers for cancer, cardiovascular conditions, and ophthalmologic therapies. Its services include organ transplantation and a regional burn treatment center. The company was founded in March 1958 and is headquartered in Washington, DC. | Hospital/Nursing Management | Director/Board Member | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Semorex, Inc. | Director/Board Member Director/Board Member | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Worldwide Clinical Research, Inc.
 Worldwide Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd., Worldwide Clinical Research, Inc. provides management consulting services to the clinical research industry. The private company is based in Overland Park, KS. The company was founded by Barbara J. Geiger. Worldwide Clinical Research was acquired by Clinipace, Inc., part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. from April 28, 2021 on November 09, 2009. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The private company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
| Oncology Clinical Research & Development | Director/Board Member | ||
| NEXGEL, INC. | Chemicals: Specialty | Director/Board Member | |
| CancerCare of New Jersey | Director/Board Member | ||
| METASTAT, INC. | Electrical Products | Chairman | |
Vidac Pharma Ltd.
 Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
| Spiegel Consultants, LLC | Founder | ||
New York University Medical Center
 New York University Medical Center Other Consumer ServicesConsumer Services Part of New York University, New York University Medical Center is a healthcare provider that offers personalized treatment for reproductive and sexual health conditions in men and women. The private company is based in New York and provides emergency and urgent care at various locations, as well as Virtual Urgent Care. NYU Langone's Community Health Needs Assessment and Service Plan aims to support behavior change and disease prevention at the neighborhood level. The American company was founded by J. Ira Harris. | Other Consumer Services | Corporate Officer/Principal | |
| Celgene Global Health | Chief Executive Officer | ||
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| PDS BIOTECHNOLOGY CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ADVAXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Epirus, Inc.
 Epirus, Inc. Aerospace & DefenseElectronic Technology Epirus, Inc. operates as a venture-backed startup that builds modern defense systems. The company was founded by Joseph Lonsdale, Grant Verstandig, John Tenet, Bo Marr, and Max Mednik and is headquartered in Hawthorne , CA. | Aerospace & Defense | Founder | |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chairman | |
| Arthritis Foundation New Jersey Chapter | Director/Board Member | ||
Zephyr Ai, Inc.
 Zephyr Ai, Inc. Packaged SoftwareTechnology Services Zephyr Ai, Inc. is a healthcare technology company based in Dallas, TX. Zephyr Ai is committed to revolutionizing drug discovery and precision medicine through partnerships and proprietary data. The company curates the world's most comprehensive healthcare dataset and uses cutting-edge artificial intelligence algorithms to generate novel insights that support patients, providers, and ongoing research. The company was founded in 2020 by Grant Lovely VerStandig, Jeff Sherman, and Yisroel Brumer. David L. Morgan has been the CEO of the company since 2022. | Packaged Software | Director/Board Member Founder | |
| AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 44 |
| Israël | 5 |
| Canada | 2 |
| India | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 6 |
| Technology Services | 4 |
| Commercial Services | 4 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 106 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 44 |
| Chairman | 33 |
| Founder | 25 |
Sterkste connecties
| Insiders | |
|---|---|
| Jerome Zeldis | 38 |
| Sol Barer | 32 |
| Robert Spiegel | 30 |
| Alan S. Roemer | 21 |
| Kenneth Carter | 18 |
| Grant Verstandig | 17 |
| Tim Bertram | 13 |
| Bruce McCreedy | 12 |
| Zheng Bin Yao | 11 |
| John Trainer | 8 |
| Alain D. Cappeluti | 8 |
| Tony Yao | 8 |
| Scott Carmer | 7 |
| Tim Stover | 7 |
| Leena Gandhi | 7 |
- Beurs
- Insiders
- Mathias Oelke
- Bedrijfsconnecties
